Table of Contents

• 1.   Market Introduction

  •   1. Objectives of the Study
      2. Market Definition
      3. Market Scope
       3.1. Years Considered for the Study
       3.2. Market Covered
      4. Currency
      5. Limitations
      6. Stakeholders

• 2.   Research Methodology

  •   1. Research Data
       1.1. Secondary Data
        1.1.1. Key Data from Secondary Sources
       1.2 . Primary Data
        1.2.1. Key Data from Primary Sources
      2. Market Size Estimation
      3. Market Breakdown and Data Triangulation
      4. Assumptions for the Study

• 3.   Executive Summary
  •   1. Market Outlook
      2. Segment Outlook
      3. Competitive Insights
    
• 4.  Companion Animal Diagnostics Market Variables, Trends and Scope

  •   1. Market Lineage Outlook
      2. Penetration and Growth Prospect Mapping
      3. Industry Value Chain Analysis
      4. Cost Analysis Breakdown
      5. Technology Overview
      6. Regulatory Framework
       6.1. Reimbursement Framework
       6.2. Standards and Compliances

• 5.   Market Overview
  •   1. Market Dynamics
       1.1. Market Driver Analysis
        1.1.1. Increasing focus of Companion Animal Diagnostics Market Companies on Brand Protection
        1.1.2. Untapped Opportunities in Emerging Regions
       1.2. Market Restraint Analysis
        1.2.1. High Cost Associated with Implementation of Predictive Analysis
       1.3. Industry Challenges
        1.3.1. Presence of Ambiguous Regulatory Framework
    
• 6.  Companion Animal Diagnostics Market Analysis Tools

  •   1. Industry Analysis - Porter’s
       1.1. Supplier Power
       1.2. Buyer Power
       1.3. Substitution Threat
       1.4. Threat from New Entrants
       1.5. Competitive Rivalry
      2. Pestel Analysis
       2.1. Political Landscape
       2.2. Environmental Landscape
       2.3. Social Landscape
       2.4. Technology Landscape
       2.5. Legal Landscape
      3. Major Deals And Strategic Alliances Analysis
       3.1. Joint Ventures
       3.2. Mergers and Acquisitions
       3.3. Licensing and Partnership
       3.4. Technology Collaborations
       3.5. Strategic Divestments
      4. Market Entry Strategies
      5. Case Studies

• 7.  Companion Animal Diagnostics Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Clinical Biochemistry
       1.1. Clinical Chemistry Analysis
        1.1.1. Clinical Chemistry Reagent Clips and Cartridges
        1.1.2. Clinical Chemistry Analyzers
       1.2. Glucose Monitoring
        1.2.1. Blood Glucose Strips
        1.2.2. Glucose Monitors
        1.2.3. Urine Glucose Strips
       1.3. Blood Gas and Electrolyte Analysis
        1.3.1. Blood Gas and Electrolyte Reagent Clips and Cartridges
        1.3.2. Blood Gas and Electrolyte Analyzers
      2. Immunodiagnostics
       2.1. Lateral Flow Assays
        2.1.1. Rapid Tests
        2.1.2. Strip Readers
       2.2. ELISA Tests
       2.3. Allergen-specific Immunodiagnostic Tests
       2.4. Immunoassay Analyzers
       2.5. Other Immunodiagnostic Products (assay tests such as agglutination tests, fluorinated agglutination tests, immunohistochemistry, Western blot tests, non-infection immunoassays, complement fixation, agar gel immunodiffusion, and serum/virus neutralization)
      3. Hematology
       3.1. Hematology Cartridges
       3.2. Hematology Analyzers
      4. Urinalysis
       4.1. Urinalysis Clips and Cartridges/Panels
       4.2. Urine Analyzers
       4.3. Urine Test Strips
      5. Molecular Diagnostics
       5.1. Polymer Chain Reaction Tests
       5.2. Microarrays
       5.3. Other Molecular Diagnostic Products (DNA sequencing, genotyping, DNA profiles, and next-generation sequencing)
      6. Other Companion Animal Diagnostic Technologies (microbiology tests and histopathology tests)

• 8.  Companion Animal Diagnostics Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Clinical Pathology
      2. Bacteriology
      3. Virology
      4. Parasitology
      5. Other Applications (pregnancy testing, genetic testing, and toxicology testing)

• 9.  Companion Animal Diagnostics Market, By Animal Type Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Dogs
      2. Cats
      3. Horses
      4. Other Companion Animals (rabbits, reptiles, pet fish, and birds)

• 10.  Companion Animal Diagnostics Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Veterinary Reference Laboratories
      2. Veterinary Hospitals and Clinics
      3. Point-of-care/In-house Testing
      4. Research Institutes and Universities

• 11.   North America Companion Animal Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. U.S.A
       2.2. Canada
       2.3. Mexico
      3. Market Size (USD Million) Forecast for North America 2023-2031

• 12.   Latin America Companion Animal Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Brazil
       2.2. Venezuela
       2.3. Argentina
       2.4. Rest of Latin America
      3. Market Size (USD Million) Forecast for Latin America 2023-2031

• 13.   Europe Companion Animal Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Germany
       2.2. U.K
       2.3. France
       2.4. Italy
       2.5. Spain
       2.6. Russia
       2.7. Poland
       2.8. Rest of Europe
      3. Market Size (USD Million) Forecast for Europe 2023-2031

• 14.   Asia Pacific Companion Animal Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Japan
       2.2. China
       2.3. India
       2.4. Australia and New Zealand
       2.5. ASEAN
       2.6. Rest of Asia Pacific
      3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

• 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. GCC
       2.2. Israel
       2.3. South Africa
       2.4. Rest of MEA
      3. Market Size (USD Million) Forecast for MEA 2023-2031

• 16.   Market Share Analysis and Competitive Landscape
  •   1. Global Landscape - Key Players, Revenue and Presence
      2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
      3. Global Emerging Companies
      4. North America - Market Share Analysis and Key Regional Players
      5. Europe - Market Share Analysis and Key Regional Players
      6. Asia Pacific - Market Share Analysis and Key Regional Players
      7. Global Key Player - Growth Matrix
    
• 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

  •   1. IDEXX Laboratories, Inc.
       1.1. Company Overview
       1.2. Product Portfolio
       1.3. SWOT Analysis
       1.4. Financial Overview
       1.5. Strategic Overview
      2. Zoetis Inc.
       2.1. Company Overview
       2.2. Product Portfolio
       2.3. SWOT Analysis
       2.4. Financial Overview
       2.5. Strategic Overview
      3. Heska Corporation
       3.1. Company Overview
       3.2. Product Portfolio
       3.3. SWOT Analysis
       3.4. Financial Overview
       3.5. Strategic Overview
      4. Thermo Fisher Scientific Inc.
       4.1. Company Overview
       4.2. Product Portfolio
       4.3. SWOT Analysis
       4.4. Financial Overview
       4.5. Strategic Overview
      5. Virbac
       5.1. Company Overview
       5.2. Product Portfolio
       5.3. SWOT Analysis
       5.4. Financial Overview
       5.5. Strategic Overview
      6. Neogen Corporation
       6.1. Company Overview
       6.2. Product Portfolio
       6.3. SWOT Analysis
       6.4. Financial Overview
       6.5. Strategic Overview
      7. Biomérieux SA
       7.1. Company Overview
       7.2. Product Portfolio
       7.3. SWOT Analysis
       7.4. Financial Overview
       7.5. Strategic Overview
      8. INDICAL Bioscience GmbH (QIAGEN N.V.)
       8.1. Company Overview
       8.2. Product Portfolio
       8.3. SWOT Analysis
       8.4. Financial Overview
       8.5. Strategic Overview
      9. Fujifilm Holdings Corporation
       9.1. Company Overview
       9.2. Product Portfolio
       9.3. SWOT Analysis
       9.4. Financial Overview
       9.5. Strategic Overview
      10. IDvet
       10.1. Company Overview
       10.2. Product Portfolio
       10.3. SWOT Analysis
       10.4. Financial Overview
       10.5. Strategic Overview
      11. Randox Laboratories, Ltd.
       11.1. Company Overview
       11.2. Product Portfolio
       11.3. SWOT Analysis
       11.4. Financial Overview
       11.5. Strategic Overview
      12. Mindray Medical International Limited (A Part of Excelsior Union Limited)
       12.1. Company Overview
       12.2. Product Portfolio
       12.3. SWOT Analysis
       12.4. Financial Overview
       12.5. Strategic Overview
      13. Skyla
       13.1. Company Overview
       13.2. Product Portfolio
       13.3. SWOT Analysis
       13.4. Financial Overview
       13.5. Strategic Overview
      14. Bionote Inc.
       14.1. Company Overview
       14.2. Product Portfolio
       14.3. SWOT Analysis
       14.4. Financial Overview
       14.5. Strategic Overview
      15. Scil Animal Care Company GmbH
       15.1. Company Overview
       15.2. Product Portfolio
       15.3. SWOT Analysis
       15.4. Financial Overview
       15.5. Strategic Overview
      16. Urit Medical Electronic Co., Ltd.
       16.1. Company Overview
       16.2. Product Portfolio
       16.3. SWOT Analysis
       16.4. Financial Overview
       16.5. Strategic Overview
      17. Eurolyser Diagnostica GmbH
       17.1. Company Overview
       17.2. Product Portfolio
       17.3. SWOT Analysis
       17.4. Financial Overview
       17.5. Strategic Overview

• 18.   Pre and Post COVID-19 Impact
  •   1. Positive influence on the healthcare industry
      2. The financial disruption of the manufacturing sector
      3. Impact of COVID-19 on emerging companies
      4. Significant mandates in the healthcare regulations initiated by administrations
      5. The overall economic slowdown of the developing and developed nations
    
• 19.   FutureWise SME Key Takeaway Points for Client